SAS Output

19-NOV-2017 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1336 20 1044 86 1047 214 1303
ERLYTX 205 2 104 6 73 12 73
GI 208 5 261 16 195 40 244
GU 428 10 522 32 390 61 371
LEUK 63 1 52 1 12 2 12
LUNG 331 5 261 25 304 50 304
LYMPH 9 0 0 1 12 2 12
MELAN 943 7 365 13 158 23 140
MMYEL 79 3 157 8 97 13 79
OTHER 37 1 52 5 61 8 49
Total 3639 54 2818 193 2349 425 2587

19-NOV-2017 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 33 2 104 6 73 11 67
CCD 1557 41 2139 107 1303 237 1443
LEUK 5 0 0 0 0 0 0
LUNG 545 10 522 47 572 87 530
OTHER 11 0 0 0 0 0 0
PREV 100 0 0 8 97 29 177
SURV 84 5 261 12 146 22 134
SXQOL 18 0 0 0 0 0 0
Total 2353 58 3026 180 2191 386 2351

19-NOV-2017 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1369 22 1148 92 1120 225 1370
CCD 1557 41 2139 107 1303 237 1443
ERLYTX 205 2 104 6 73 12 73
GI 208 5 261 16 195 40 244
GU 428 10 522 32 390 61 371
LEUK 68 1 52 1 12 2 12
LUNG 876 15 783 72 877 137 834
LYMPH 9 0 0 1 12 2 12
MELAN 943 7 365 13 158 23 140
MMYEL 79 3 157 8 97 13 79
OTHER 48 1 52 5 61 8 49
PREV 100 0 0 8 97 29 177
SURV 84 5 261 12 146 22 134
SXQOL 18 0 0 0 0 0 0
Total 5992 112 5844 373 4541 811 4938

19-NOV-2017 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 578 11 574 52 633 112 682
ERLYTX 144 2 104 3 37 7 43
GI 154 4 209 9 110 24 146
GU 300 5 261 18 219 41 250
LEUK 50 1 52 1 12 2 12
LUNG 225 5 261 21 256 36 219
LYMPH 9 0 0 1 12 2 12
MELAN 502 7 365 12 146 21 128
MMYEL 78 2 104 7 85 12 73
OTHER 37 1 52 5 61 8 49
Total 2077 38 1982 129 1571 265 1614

19-NOV-2017 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 33 2 104 6 73 11 67
CCD 1347 31 1618 78 950 170 1035
LEUK 5 0 0 0 0 0 0
LUNG 383 7 365 35 426 68 414
OTHER 11 0 0 0 0 0 0
PREV 84 0 0 8 97 28 170
SURV 53 4 209 9 110 14 85
SXQOL 18 0 0 0 0 0 0
Total 1934 44 2296 136 1656 291 1771

19-NOV-2017 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 631 13 678 61 743 125 761
CCD 1347 31 1618 78 950 170 1035
ERLYTX 144 2 104 3 37 7 43
GI 154 4 209 9 110 24 146
GU 303 5 261 18 219 41 250
LEUK 55 1 52 1 12 2 12
LUNG 608 12 626 56 682 104 633
LYMPH 9 0 0 1 12 2 12
MELAN 496 7 365 12 146 21 128
MMYEL 78 2 104 7 85 12 73
OTHER 66 1 52 5 61 13 79
PREV 84 0 0 8 97 28 170
SURV 53 3 157 9 110 14 85
SXQOL 18 0 0 0 0 0 0
Total 4046 81 4226 268 3264 563 3427

19-NOV-2017 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1132 14 730 63 767 173 1053
ERLYTX 131 2 104 6 73 8 49
GI 155 4 209 14 170 33 201
GU 385 8 417 29 353 51 310
LEUK 38 0 0 0 0 0 0
LUNG 283 5 261 20 244 39 237
MELAN 906 7 365 12 146 17 103
Total 3030 40 2086 144 1753 321 1953

19-NOV-2017 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1703 33 1722 113 1376 242 1473
AFFIL 136 1 52 9 110 18 110
CCOP/NCORP 2172 48 2505 143 1741 296 1802
Non-SWOG 1978 27 1409 105 1278 252 1534
Total 5989 109 5688 370 4505 808 4919

19-NOV-2017 6:10

STUDIES OPENED THIS MONTH

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LUNG S1619 Meso,Stg I-III, Nadj chemo/Atezmb->Atezmb+SOC 1 Y 03-NOV-17
LUNG S1619 Meso,Stg I-III, Nadj chemo/Atezmb->Atezmb+SOC 2 Y 03-NOV-17
LUNG S1619 Meso,Stg I-III, Nadj chemo/Atezmb->Atezmb+SOC 3 Y 03-NOV-17

19-NOV-2017 6:10

STUDIES CLOSED THIS MONTH

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LUNG 8811 NSCLC, Stage III,ChemoRT+ABT-888 1 N 23-OCT-17

19-NOV-2017 6:10

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Registrations
CCD S1415CD TrACER CSF Standing Order Intervention for FN 1 38
BREAST S1207 Brst,Adj,Endocrine+/-Everolimus 1 7
LUNG A151216 ALCHEMIST0 - screening 1 6
LUNG A151216 ALCHEMIST0 - screening 0 6
MELAN S1320 Adv, BRAF mut, Inter v Contin 1 6
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 2 5
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 5
BREAST A011401 Breast, adj, Stage II/III HER2-, weight loss 1 4
LUNG S1400 SCCA,Adv, Biomarker Master 1 4
GU S1602 Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 4
BREAST A011401 Breast, adj, Stage II/III HER2-, weight loss 2 3
MMYEL E1A11 MM, frontline, BLD vs CLD 1 3
SURV S1316 Compar. Effectiv. Trial for MBO 1 3
CCD S1417CD Colorectal, Cost Cohort Study 1 3